Catalyst Capital Advisors’s Verastem VSTM Stock Holding History

Catalyst Capital Advisors’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-8,750	Closed	-$792K	–	619
2015 Q2	$792K	Hold	8,750	–	–	0.09%	176
2015 Q1	$1.07M	Buy	8,750 +6,667	+320%	+$699K	0.12%	140
2014 Q4	$229K	Buy	+2,083	New	+$225K	0.03%	298

Other funds holding VSTM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $407M AUM 87.11% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

DVC

Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

MAM

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Catalyst Capital Advisors's VSTM Position: Q3 2015 in Review

Catalyst Capital Advisors sold out of Verastem (VSTM) in Q3 2015, closing a stake of 8,750 shares — an estimated $792K sold.

Catalyst Capital Advisors first reported a position in VSTM in Q4 2014 and held it in 3 quarters. The position peaked at $1.07M in Q1 2015. 76 funds tracked by Wall St. Rank hold VSTM as of Q3 2015.

Catalyst Capital Advisors reported no remaining Verastem position as of Q3 2015 after selling out during the quarter.
Catalyst Capital Advisors sold 8,750 Verastem shares in Q3 2015, an estimated $792K.
Catalyst Capital Advisors first reported a position in Verastem in Q4 2014 and held it in 3 quarters.
Catalyst Capital Advisors's Verastem position peaked at $1.07M in Q1 2015.
76 funds tracked by Wall St. Rank held Verastem as of Q3 2015.

Based on Catalyst Capital Advisors's 13F filing for Q3 2015, filed 12 Nov 2015.